2 completed, 2 withdrawn, 1 not yet recruiting, 1 terminated. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 2, Withdrawn 2, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Wockhardt: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Cefepime-Zidebactam, Ceftazidime-avibactam with or without Colistin - Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | Phase 3 | Not yet recruiting | Wockhardt | 324 | 2026-10-28 | 2026-10-21 |
| Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) WCK 4282 (FEP-TAZ) 4 g, Meropenem, ciprofloxacin 500 mg Optional Oral Switch - Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Unknown | Wockhardt | 1004 | 2024-01-01 | 2023-07-17 |
| Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) Cefepime-zidebactam (FEP-ZID), Meropenem - Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Completed | Wockhardt | 530 | 2022-08-28 | 2026-05-22 |
| Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Oral Levonadifloxacin/Linezolid Tablet, Intravenous Levonadifloxacin/Linezolid Infusion - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Wockhardt | 501 | 2017-08-25 | 2020-06-29 |
| Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics Insulin Lispro - Type I Diabetes | Phase 3 | Withdrawn | Wockhardt | 2012-02-01 | 2013-01-25 | |
| Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Wosulin (N or 70/30 with R), NovolinĀ® (N or 70/30 with R) - Type I Diabetes | Phase 3 | Terminated | Wockhardt | 134 | 2011-03-01 | 2023-06-23 |
| Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients Wockhardt's Insulin Analogue (Recomb), LantusĀ® - Type I Diabetes | Phase 3 | Withdrawn | Wockhardt | 2019-10-08 |
Meropenem (2) · cefepime-zidebactam (2) · Ciprofloxacin (1) · Colistin (1) · Insulin (1) · Insulin Glargine (1) · Insulin Lispro (1) · Linezolid (1) · avibactam, ceftazidime drug combination (1) · levonadifloxacin (1)
India (4) · Bulgaria (2) · Lithuania (2) · Poland (2) · United States (2) · Bosnia and Herzegovina (1) · China (1) · Croatia (1) · Estonia (1) · France (1) · Georgia (1) · Greece (1) · Italy (1) · Mexico (1) · Moldova (1)
Ashima Bhatia, M.D. (1) · Dr Ashima Bhatia, M.D. (1) · Dr.Rasendrakumar Jha (1) · Manishkumar D Shah, PhD (1) · Rakesh Chugh, MD (1)